Company profile THAR
After 39 days of this quarter the interest is at 97.0. Based on that we can calculate that during remaining 52 days it will total up to 226.0. Tharimmune expected interest is significantly higher compared to previous quarter (+186.1%) and same quarter last year (+247.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 20 inf% QoQ | 175 775.0% QoQ | 108 -38.3% QoQ |
| 2020 | 60 inf% YoY -44.4% QoQ | 66 230.0% YoY 10.0% QoQ | 116 -33.7% YoY 75.8% QoQ | 35 -67.6% YoY -69.8% QoQ |
| 2021 | 33 -45.0% YoY -5.7% QoQ | 56 -15.2% YoY 69.7% QoQ | 77 -33.6% YoY 37.5% QoQ | 21 -40.0% YoY -72.7% QoQ |
| 2022 | 194 487.9% YoY 823.8% QoQ | 0 -100.0% YoY -100.0% QoQ | 92 19.5% YoY inf% QoQ | 18 -14.3% YoY -80.4% QoQ |
| 2023 | 65 -66.5% YoY 261.1% QoQ | 87 inf% YoY 33.8% QoQ | 136 47.8% YoY 56.3% QoQ | 79 338.9% YoY -41.9% QoQ |
| 2024 | 97 49.2% YoY 22.8% QoQ | - | - | - |
The average 5 years interest of Tharimmune was 5.88 per week. The last year interest of Tharimmune compared to the last 5 years has changed by 39.97%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 24.7%.
There is not enough data for Tharimmune Tharimmune profile to provide analysis
There is not enough data for Tharimmune Tharimmune profile to provide correlation calculation
There is not enough data for Tharimmune Tharimmune profile to provide analysis
There is not enough data for Tharimmune company to provide analysis
There is not enough data for Tharimmune company to provide correlation calculation
There is not enough data for Tharimmune company to provide analysis
There is not enough data for Tharimmune healthcare to provide analysis
There is not enough data for Tharimmune healthcare to provide correlation calculation
There is not enough data for Tharimmune healthcare to provide analysis
There is not enough data for Tharimmune biotechnology to provide analysis
There is not enough data for Tharimmune biotechnology to provide correlation calculation
There is not enough data for Tharimmune biotechnology to provide analysis
There is not enough data for Tharimmune therapeutic candidates to provide analysis
There is not enough data for Tharimmune therapeutic candidates to provide correlation calculation
There is not enough data for Tharimmune therapeutic candidates to provide analysis
There is not enough data for Tharimmune antibodies to provide analysis
There is not enough data for Tharimmune antibodies to provide correlation calculation
There is not enough data for Tharimmune antibodies to provide analysis
There is not enough data for Tharimmune immuno-oncology to provide analysis
There is not enough data for Tharimmune immuno-oncology to provide correlation calculation
There is not enough data for Tharimmune immuno-oncology to provide analysis
There is not enough data for Tharimmune solid tumors. to provide analysis
There is not enough data for Tharimmune solid tumors. to provide correlation calculation
There is not enough data for Tharimmune solid tumors. to provide analysis